Rare diseases
Investigational molecules
Locations
Back to Italy1 011 clinical trials in Arezzo, Italy across 1 research site. Every trial is listed in the EU Clinical Trials Register and updated daily.
Our site in ItalyStudi-Clinici.it(opens in a new tab)Study on the Effectiveness and Safety of Lebrikizumab for Adults and Adolescents with Moderate-to-Severe Atopic Dermatitis
ItalyStudy on the Safety and Effectiveness of Gefurulimab for Adults with Generalized Myasthenia Gravis
ItalyStudy on TAR-200 and Cetrelimab for High-Risk Bladder Cancer Patients Not Responding to BCG and Unable or Unwilling to Have Surgery
ItalyStudy on the Effects of Amikacin Liposome Inhalation, Azithromycin, and Ethambutol in Adults with Newly Diagnosed Nontuberculous Mycobacterial Lung Infection
ItalyStudy on the Safety and Effectiveness of Padeliporfin Therapy for Patients with Low-Grade Upper Tract Urothelial Cancer
ItalyStudy of Secukinumab for Maintaining Remission in Patients with Non-Radiographic Axial Spondyloarthritis
ItalyStudy on the Effectiveness and Safety of Belzupacap Sarotalocan for Patients with Small Choroidal Melanoma or Indeterminate Lesions
ItalyStudy on the Effectiveness and Safety of OCS-01 Eye Drops with Dexamethasone for Patients with Diabetic Macular Edema
ItalyStudy on Acalabrutinib with Drug Combination for Patients 75 and Older with Untreated Diffuse Large B-Cell Lymphoma
ItalyStudy on Fipaxalparant for Patients with Idiopathic Pulmonary Fibrosis
ItalyStudy of Raludotatug Deruxtecan for Patients with Platinum-resistant High-grade Ovarian, Primary Peritoneal, or Fallopian Tube Cancer
ItalyStudy of mRNA-4157 and Pembrolizumab for Patients with Resectable Locally Advanced Cutaneous Squamous Cell Carcinoma
ItalyThe busiest research cities in the country
What the registry says about research in the country
Extensive research focusing on bladder cancer treatments, including innovative therapies combining immunotherapy with established treatments. Studies evaluate new approaches for both muscle-invasive and non-muscle invasive disease.
Multiple trials exploring targeted treatments for patients with various stages of disease progression.
Advanced studies examining new therapeutic approaches for metastatic prostate cancer, including novel drug combinations and targeted therapies for specific genetic mutations.
Investigating innovative treatment sequences and combinations to improve patient outcomes.
Cutting-edge research in renal cell carcinoma treatment, exploring immunotherapy combinations and targeted approaches for both early-stage and metastatic disease.
Focus on improving survival rates through novel therapeutic strategies.
Tell us about your condition – we search every trial in Europe and connect you with the right site.
